Singapore - Students,
young entrepreneurs and start-ups joined the From Molecules to Medicines
(FMTM) ‘Serious Game’ tournament at the innovfest
unbound to mark the global debut of the FMTM Serious Games by Bayer.
The annual innovfest unbound is the anchor event of Smart Nation Innovations, a week-long
series of events that showcase Asia’s most innovative developments. In 2018, they
have welcome over 12,000 entrepreneurs, brands, corporates, investors and tech
start-ups from 100+ countries to meet and share new ideas, build partnerships
and celebrate digital disruption.
In partnership with Infocomm Media Development
Authority (IMDA), innovfest unbound is organized by NUS Enterprise and unbound
and is Southeast Asia’s most celebrated innovation festival. It is the place
where brands connect with disruptive innovation and explore Asian
opportunities.
This year's innovation showcase was held at
Marina Bay Sands, Singapore, from 5 to 6 June 2018.
For the first time, through FMTM Serious Games, the public was able to take a peek behind the scene at the
different stages of research and development (R&D) required to create new
and potentially life-saving drugs.
Mr. Claus Zieler, Senior Vice President &
Head of Commercial Operations, Bayer Pharmaceuticals Division Asia Pacific
said, “We launched the new From Molecules to Medicine interactive
edutainment to give the public an understanding of the elaborate and complex
processes required to develop breakthrough therapies. We hope this will
encourage the wider community to take an interest in science and research, and
eventually contribute their ideas to solving the region’s healthcare
challenges.”
Medicines help save
lives, overcome diseases and increase patients' quality of life. But how do you
invent and develop a new medicine? Get to know a unique side of drug research
and development and play away with the Bayer "From Molecules to
medicine" Games.
The players accomplished various steps to
create a new drug starting with identifying a target where a drug could act on,
finding a suitable molecule, through the different preclinical and clinical
development stages, and finally obtaining the regulatory approvals necessary to
prescribe the new drug to the patients who need it. Four teams with the highest
scores each won prizes worth S$500 and a board game developed by Bayer and
Taiwanese start-up BIG FUN.
The games are part of the new FMTM app and
are available to download for free from the Apple Store (iOS)